Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
MCRB
$2.94
+0.34%
MCRB
· Seres Therapeutics, Inc.
$2.94
+0.01 (+0.34%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“these conditions raise substantial doubt about the Company's ability to continue as a going concern. ... As a result, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 5, 2026
Market Cap
$34.99M
Shares
9.94M
Volume · Oct 2
100.95K
Avg daily vol (3M)
74.96K
All webcasts
Earnings call · FY2019 Q4
Seres Therapeutics, Inc. (MCRB) Q4 2019 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$7.62M
-28.3% YoY
Net income
-$18.78M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 2, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 2, 2020 · complete as-filed document